Menu

From September 2018, Tudor Reilly Health has rebranded as Raremark.

With our experience in hard-to-reach indications, a global network of clinical research professionals, and regulatory know-how, the Raremark team engages patients in clinical research, improves the informed consent process, and accelerates recruitment; on budget, on time – every time.

How we do that

Branding

Branding

We help to give clinical studies an identity, essential in competitive therapeutic areas

Online recruitment

Online recruitment

Our online recruitment tactics increase referral rates through previously untapped patient populations, saving time and money

Local support

Local support

Through our global network and localised print materials, we provide tailored support to clinical trial sites

eConsent

eConsent

Our engaging eConsent materials help guide patients and caregivers through the complex process of informed consent

For more information on how Raremark can support your clinical trial, please contact our Client Services Director, Peter Coë. Email: peter.coe@raremark.com